Condition: Ph Positive ALL · Sponsor: Group for Research in Adult Acute Lymphoblastic Leukemia
The objective of this retrospective study is to examine the outcome of patients who relapse with Ph+ ALL and to potentially identify response profiles in order toadvance the treatment regimens that can be offered.
This description comes directly from the study's public registry record.
Aline SCHMIDT, MD/PhD · 241354482 · alschmidt@chu-angers.fr
Véronique LHERITIER, Central coordination · 0478862239 · veronique.lheritier@chu-lyon.fr
Always discuss trial participation with your own doctor first.
| GRAALL | Pierre-Bénite, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07433400